Tumor-targeting compounds
US10202421B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Inventor
Key dates
| Filing date | Sep 2, 2016 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Sep 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a novel compounds targeting human cancer cells, a method for synthesis of such compounds, and use of such compounds in treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.